The Diagnostic Pitfall: DOACs and Activated Partial Thromboplastin Time
Mohamed Hanafy Morsy, Associate Professor of Clinical Pathology, Hematopathologist at Makkah Health Cluster, posted on LinkedIn:
”Lab staff + Cardiology Colleagues – Quick 30-second read that will save you confusion forever
The Diagnostic Pitfall: Direct Oral Anticoagulants (DOACs) and Activated Partial Thromboplastin Time (aPTT)
Scenario: A patient is receiving therapeutic anticoagulation with a direct Factor Xa inhibitor (e.g., Apixaban, Rivaroxaban). Routine or emergent coagulation screening returns an aPTT result that is unmeasurably short, <25 seconds, or within the institutional reference interval.
Your reaction?
A) Panic – “The patient has NO anticoagulation”
B) Call the lab – “Your machine is broken”
C) Relax – This is 100 % normal and expected
The correct answer is C
Apixaban (and all DOACs) have minimal to no effect on aPTT.
A super-low aPTT does NOT mean the drug isn’t working.
Ideal lab comment to add automatically when apixaban is on the chart:
“The aPTT result is not validated for assessing the efficacy of Direct Factor Xa Inhibitors. If quantitative assessment of drug concentration is required, order the drug-specific Chromogenic Anti-Xa Assay.”
Let’s stop the 2 a.m. pages to hematology for this.”

Keep up with Hemostasis Today.
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia